Home » Research » Certification

Certification

The Immun4Cure University Hospital Institute (IHU) is dedicated to understanding the pathophysiological mechanisms of autoimmunity, identifying new biomarkers for diagnosing and predicting the flare and progression of autoimmune diseases, and developing innovative new biotherapies to address unmet medical needs.

Why join the Immun4Cure team?

Obtain a mark of national excellence awarded to highly competitive projects.
Increase your visibility.
Gain a competitive advantage when applying for funding.
Participate in internal seminars.
Access innovative technologies.
Be part of a stimulating, interdisciplinary environment.

Be part of a strong ecosystem focused on innovation in immunotherapy.

How to join the Immun4Cure team?

Research teams, clinical departments, technology platforms and private partners are all eligible to apply.
The attached application form must be completed and sent to severine.kremer@umontpellier.fr.
If your project is deemed eligible, you will present it to the Work Package (WP) leaders.
The Valorisation Committee will then decide on certification based on the opinions issued by the WP leaders.
A written response will be sent to you within one month.

Eligibility criteria

Collaboration with an Immun4cure team.
Scientific consistency with Immun4Cure’s strategic priorities.
Scientific excellence.
Potential for transfer or clinical application (translational impact).
Potential for scientific, technological or industrial exploitation.
Commitment to acknowledging Immun4Cure in publications resulting from labelled work.

Expected commitments from a labelled team

Participation in meetings/seminars at least once a year.
Production of an annual activity report (max. 1 page).
Sharing of resources or data where relevant.
Integration of students or postdocs into cross-disciplinary programmes.
Mention of the Immun4Cure label in funding applications.
Acknowledgement of IHU Immun4Cure in publications.

Duration and renewal of the label

The Immun4Cure label is granted for three years and is renewable.
Reassessment is based on annual activity reports, impact, and the continuity of collaboration(s), etc.

Timeline

Applications are accepted as they are submitted.